The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Dominic Allocco
Showing 1-14 of 14 articles
A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis
Hamm C,
Dörr O,
Woehrle J,
Krackhardt F,
Ince H,
Zeus T,
Berland J,
Piot C,
Roubille F,
Schult I,
Allocco D,
Nef H
July 17, 2020 | 10.4244/EIJ-D-19-00051
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R,
Worthley S,
Whitbourn R,
Montarello J,
Newcomb A,
Allocco D,
Meredith I
December 7, 2018 | 10.4244/EIJ-D-18-00664
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Dubois C,
Dens J,
Farah B,
Carrié D,
Walsh S,
Oldroyd K,
Varenne O,
El-Jack S,
Moreno R,
Christen T,
Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study
Han Y,
Liu H,
Yang Y,
Zhang J,
Xu K,
Fu G,
Su X,
Jiang T,
Pang W,
Chen J,
Yuan Z,
Li H,
Wang H,
Hong T,
Liu H,
Sun F,
Allocco D,
Zhang M,
Dawkins K
November 20, 2017 | 10.4244/EIJ-D-17-00271
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I,
Dumonteil N,
Blackman D,
Tchétché D,
Walters D,
Hildick-Smith D,
Manoharan G,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Feldman T,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N,
Meredith I,
Blackman D,
Tchétché D,
Hildick-Smith D,
Spence M,
Walters D,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem N,
Houle V,
Allocco D,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)
Tamburino C,
Capodanno D,
Erglis A,
Menown I,
Horvath I,
Moreno R,
Gilbert T,
Crowley J,
Calabria P,
Allocco D,
Dawkins K
March 20, 2015 | 10.4244/EIJY15M01_01
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I,
Worthley S,
Whitbourn R,
Antonis P,
Montarello J,
Newcomb A,
Lockwood S,
Haratani N,
Allocco D,
Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Weissman N,
Barragan P,
Scott D,
Valdés Chávarri M,
West N,
Kelbæk H,
Whitbourn R,
Walters D,
Kubica J,
Thuesen L,
Masotti M,
Banning AP,
Sjogren I,
Stables R,
Allocco D,
Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Boston Scientific Lotus valve
Meredith I,
Hood K,
Haratani N,
Allocco D,
Dawkins K
September 30, 2012 | 10.4244/EIJV8SQA12
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials
Kereiakes D,
Popma J,
Cannon L,
Kandzari D,
Kimmelstiel C,
Meredith I,
Teirstein P,
Verheye S,
Allocco D,
Dawkins K,
Stone G
June 27, 2012 | 10.4244/EIJV8I2A32
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
Meredith I,
Whitbourn R,
Scott D,
El-Jack S,
Zambahari R,
Stone G,
Teirstein P,
Starzyk R,
Allocco D,
Dawkins K
May 17, 2011 | 10.4244/EIJV7I1A15
First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent
Ormiston J,
Lefèvre T,
Grube E,
Allocco D,
Dawkins K
May 25, 2010
Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial
Hopkins L,
Myla S,
Grube E,
Eles G,
Dave R,
Jaff M,
Allocco D
April 12, 2010
1
Latest news
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
EUROPCR LATE BREAKING
SavvyWire in TAVI
FREE ARTICLE - Josep Rodés-Cabau et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke